Clinical Outcomes and Predictive Factors in Adrenalectomy: A Retrospective Cohort Study

Document Type : Original Research

Authors

1 Department of General Surgery, School of Medicine, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

2 Department of Pathology, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

3 Breastfeeding Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Abstract
Background & Objective: Adrenal tumors present a notable prevalence of 4-7% in individuals above 40 years old. Current guidelines recommend adrenalectomy for hormone-secreting, potentially malignant, or large (>4 cm) lesions. However, the outcomes of adrenalectomy and their clinical-pathological associations remain poorly defined. This study assessed adrenalectomy outcomes and explored its clinical, demographic, and pathologic correlates.
Methods: In this retrospective cohort study, the medical records of all patients who underwent adrenalectomy from March 2016 to March 2021 at a referral center in Tehran were reviewed. Also, a clinical follow-up via telephone was conducted. The chi-square test, independent t-test, and analysis of variance were utilized for statistical analysis.
Results: Data from a total of 75 patients (55 females) were reviewed. The mean age of the participants was 42.67 years. Of them, 60%, 22.7%, 14.7%, and 1.3% had pheochromocytoma, Cushing's syndrome, Conn's syndrome, and insulinoma, respectively. Malignancy was associated with greater tumor size (p<0.000) and mitotic rate (p=0.046), and the presence of necrosis (p=0.001), and capsular and vascular invasion (p<0.000). Clinical follow-up visits of 45 patients indicated 84.4% showed a complete response to the treatment (surgical ± medical). Treatment response was significantly influenced by approach (laparoscopic favored; p=0.001), surgery duration (<150 minutes better; p=0.017), mass pathology (adenoma favored; p=0.034), and capsular invasion (absence better; p=0.012).
Conclusion: Adrenalectomy outcomes were significantly affected by surgical approach and tumor pathology, notably capsular invasion. Larger studies are needed to determine the predictive values of clinical and pathologic variables in adrenalectomy for adrenal tumors.

Keywords

Subjects


Copyright © 2026. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license also allows users to adapt, remix, transform, and build upon the material for any purpose, including commercial use.

1.        Ebbehoj A, Li D, Kaur RJ, Zhang C, Singh S, Li T, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(11):894-902. [DOI:10.1016/S2213-8587(20)30314-4] [PMID]
2.        Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, et al. Adrenal Incidentaloma. Endocrine Reviews. 2020;41(6):775-820. [DOI:10.1210/endrev/bnaa008] [PMID] [PMCID]
3.        Lam AK. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol. 2017;28(3):213-27.      [DOI:10.1007/s12022-017-9484-5] [PMID]
4.        Lloyd RV. Adrenal cortical tumors, pheochromocytomas and paragangliomas. Modern Pathology. 2011;24:S58-S65. [DOI:10.1038/modpathol.2010.126] [PMID]
5.        Sweeney AT, Hamidi O, Dogra P, Athimulam S, Correa R, Blake MA, et al. Clinical Review: The Approach to the Evaluation and Management of Bilateral Adrenal Masses. Endocrine Practice. 2024;30(10):987-1002. [DOI:10.1016/j.eprac.2024.06.015] [PMID]
6.        Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, et al. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol. 2022;33(1):155-96. [PMCID] [DOI:10.1007/s12022-022-09710-8] [PMID]
7.        Bancos I, Prete A. Approach to the Patient With Adrenal Incidentaloma. J Clin Endocrinol Metab. 2021;106(11):3331-53. [DOI:10.1210/clinem/dgab512] [PMID] [PMCID]
8.        Samsel R, Cichocki A, Roszkowska-Purska K, Papierska L, Koalasińska-Ćwikła A, Karpeta E, et al. Adrenal metastases - long-term results of surgical treatment, single-centre experience. Contemp Oncol (Pozn). 2020;24(1):29-33.          [DOI:10.5114/wo.2020.93679] [PMID] [PMCID]
9.        Sperling J. Adrenal neuroblastoma. American Journal of Obstetrics & Gynecology. 2021;225(5):B5-B6. [DOI:10.1016/j.ajog.2021.06.037] [PMID]
10.     Rezkallah EMN, Hanna RS, Elsaify WM. Adrenal Lymphoma: Case Reports and Mini-review. Int J Endocrinol Metab. 2022;20(4):e128386.      [DOI:10.5812/ijem-128386] [PMID] [PMCID]
11.     Jing Y, Hu J, Luo R, Mao Y, Luo Z, Zhang M, et al. Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population : A Cross-Sectional Study. Ann Intern Med. 2022;175(10):1383-91. [DOI:10.7326/M22-1619] [PMID]
12.     Iñiguez-Ariza NM, Kohlenberg JD, Delivanis DA, Hartman RP, Dean DS, Thomas MA, et al. Clinical, Biochemical, and Radiological Characteristics of a Single-Center Retrospective Cohort of 705 Large Adrenal Tumors. Mayo Clin Proc Innov Qual Outcomes. 2018;2(1):30-9. [PMID] [PMCID] [DOI:10.1016/j.mayocpiqo.2017.11.002]
13.     Ahn SH, Kim JH, Baek SH, Kim H, Cho YY, Suh S, et al. Characteristics of Adrenal Incidentalomas in a Large, Prospective Computed Tomography-Based Multicenter Study: The COAR Study in Korea. Yonsei Med J. 2018;59(4):501-10.  [DOI:10.3349/ymj.2018.59.4.501] [PMID] [PMCID]
14.     Ichijo T, Ueshiba H, Nawata H, Yanase T. A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features. Endocr J. 2020;67(2):141-52. [DOI:10.1507/endocrj.EJ18-0486] [PMID]
15.     Low G, Sahi K. Clinical and imaging overview of functional adrenal neoplasms. International Journal of Urology. 2012;19(8):697-708. [DOI:10.1111/j.1442-2042.2012.03014.x] [PMID]
16.     Germain A, Klein M, Brunaud L. Surgical management of adrenal tumors. J Visc Surg. 2011;148(4):e250-61. [DOI:10.1016/j.jviscsurg.2011.06.003] [PMID]
17.     Bhat HS, Tiyadath BN. Management of Adrenal Masses. Indian J Surg Oncol. 2017;8(1):67-73. [DOI:10.1007/s13193-016-0597-y] [PMID] [PMCID]
18.     Uludağ M, Aygün N, İşgör A. Surgical Indications and Techniques for Adrenalectomy. Sisli Etfal Hastan Tip Bul. 2020;54(1):8-22.
19.     Zeiger MA, Siegelman SS, Hamrahian AH. Medical and surgical evaluation and treatment of adrenal incidentalomas. J Clin Endocrinol Metab. 2011;96(7): 2004-15. [DOI:10.1210/jc.2011-0085] [PMID]
20.     Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract. 2009;15(5):450-3. [DOI:10.4158/EP.15.5.450] [PMID]
21.     Madani A, Lee JA. Surgical Approaches to the Adrenal Gland. Surg Clin North Am. 2019;99(4):773-91. [DOI:10.1016/j.suc.2019.04.013] [PMID]
22.     Smith CD, Weber CJ, Amerson JR. Laparoscopic adrenalectomy: new gold standard. World J Surg. 1999;23(4):389-96. [DOI:10.1007/PL00012314] [PMID]
23.     Ball MW, Hemal AK, Allaf ME. International Consultation on Urological Diseases and European Association of Urology International Consultation on Minimally Invasive Surgery in Urology: laparoscopic and robotic adrenalectomy. BJU Int. 2017;119(1):13-21. [DOI:10.1111/bju.13592] [PMID]
24.     Autorino R, Bove P, De Sio M, Miano R, Micali S, Cindolo L, et al. Open Versus Laparoscopic Adrenalectomy for Adrenocortical Carcinoma: A Meta-analysis of Surgical and Oncological Outcomes. Ann Surg Oncol. 2016;23(4):1195-202.            [DOI:10.1245/s10434-015-4900-x] [PMID]
25.     Mihai R. Open adrenalectomy. Gland Surg. 2019;8(Suppl 1):S28-s35.      [DOI:10.21037/gs.2019.05.10] [PMID] [PMCID]
26.     Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. [PMID] [PMCID]      [DOI:10.1371/journal.pmed.1001885]
27.     Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31-s4.   [DOI:10.4103/sja.SJA_543_18] [PMID] [PMCID]
28.     Goodyear MD, Krleza-Jeric K, Lemmens T. The Declaration of Helsinki. Bmj. 2007;335(7621):624-5. [DOI:10.1136/bmj.39339.610000.BE] [PMID] [PMCID]
29.     Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery. 2008;143(6):759-68. [DOI:10.1016/j.surg.2008.02.007] [PMID]
30.     Picard C, Orbach D, Carton M, Brugieres L, Renaudin K, Aubert S, et al. Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review. Mod Pathol. 2019;32(4):546-59. [DOI:10.1038/s41379-018-0174-8] [PMID]
31.     Gan L, Peng L, Meng C, Zheng L, Zeng Z, Ge S, et al. The role of laparoscopic adrenalectomy in the treatment of large pheochromocytomas (>6 cm): a meta-analysis and systematic review. Int J Surg. 2023;109(5):1459-69. [PMID] [PMCID]     [DOI:10.1097/JS9.0000000000000389]
32.     Hou Q, Zhang B, Liu J, Luo Y, Shang P. Clinical Efficacy Analysis of Different Surgical Methods for Giant Adrenal Tumors (≥10 cm): A Single-Center Study of 44 Cases. J Laparoendosc Adv Surg Tech A. 2023;33(7):672-7. [DOI:10.1089/lap.2023.0078] [PMID]
Volume 21, Issue 1
Winter 2026
Pages 29-40

  • Receive Date 29 January 2025
  • Revise Date 02 August 2025
  • Accept Date 10 October 2025